InvestorsHub Logo
Followers 13
Posts 4329
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 6:13:52 PM

Monday, November 16, 2020 6:13:52 PM

Post# of 18220
or Immune Therapeutics (OTCPK:IMUN +362.0%) the combination of Cytocom and Cleveland BioLabs business means that shareholders who hold a considerable stake in Cytocom can realize value.$IMUN